NEW YORK – Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall […]
Analysis: Ozempic on Wall Street’s List for 2027 Medicare Drug Negotiations Read More »
COPENHAGEN – Novo Nordisk’s (NYSE: NVO) Pharmatech unit will build a 1.5 billion Danish crown ($221 million) plant in Denmark
Novo Nordisk (NYSE: NVO) to Build $220 Million Raw Materials Plant in Denmark Read More »
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
Doctors Face Hurdles in Securing Wegovy for Older Americans with Heart Disease Read More »
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its
Novo Nordisk (NYSE: NVO) Stock Slides After Wegovy Sales Disappoint Read More »
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) posted second-quarter operating profit below expectations, raised its 2024 sales forecast but
LONDON/WASHINGTON – Novo Nordisk’s (NYSE: NVO) decision to stop selling its long-acting insulin Levemir in the United States has left
Swiss drugmaker Roche plans to accelerate the development of its anti-obesity drugs to challenge rivals like Eli Lilly (NYSE: LLY)
Roche to Fast-track Anti-Obesity Drug Development to Compete with Rivals: FT Report Read More »
On Friday, the U.S. Food and Drug Administration warned patients and doctors about dosing errors associated with compounded versions of
US FDA Warns About Dosing Risks with Compounded Versions of Novo’s Weight-Loss Drug Read More »
AMSTERDAM/COPENHAGEN – Danish drugmaker Novo Nordisk (NYSE: NVO) said on Wednesday it was disappointed with the recommendation to the Netherlands
Copyright © 2025 abbonews.com
